Free Trial

Beigene (ONC) Financials

Beigene logo
$230.36 +22.05 (+10.59%)
As of 04/11/2025 04:00 PM Eastern
Annual Income Statements for Beigene

Annual Income Statements for Beigene

This table shows Beigene's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
-57 -119 -93 -674 -949 -1,625 -1,458 -2,004 -882 -645
Consolidated Net Income / (Loss)
-57 -119 -93 -674 -951 -1,629 -1,458 -2,004 -882 -645
Net Income / (Loss) Continuing Operations
-57 -119 -93 -674 -951 -1,629 -1,458 -2,004 -882 -645
Total Pre-Tax Income
-57 -119 -91 -690 -944 -1,618 -1,439 -1,961 -826 -533
Total Operating Income
-57 -117 -98 -706 -960 -1,658 -1,439 -1,790 -1,208 -568
Total Gross Profit
8.82 1.07 233 170 357 238 1,011 1,129 2,079 3,216
Total Revenue
8.82 1.07 238 198 428 309 1,176 1,416 2,459 3,810
Operating Revenue
8.82 1.07 238 198 428 309 1,176 1,416 2,459 3,810
Total Cost of Revenue
0.00 0.00 4.97 29 71 71 165 286 380 594
Operating Cost of Revenue
0.00 0.00 4.97 29 71 71 165 286 380 594
Total Operating Expenses
66 118 332 875 1,317 1,896 2,450 2,919 3,287 3,784
Selling, General & Admin Expense
7.31 20 63 195 388 600 990 1,279 1,508 1,831
Research & Development Expense
58 98 269 679 927 1,295 1,459 1,641 1,779 1,953
Total Other Income / (Expense), net
-0.36 -2.10 7.39 16 16 39 0.15 -171 382 35
Interest & Investment Income
- - - - - - - 52 74 48
Other Income / (Expense), net
-0.92 -2.49 12 1.99 7.17 37 16 -224 308 -13
Income Tax Expense
0.00 0.05 2.24 -16 6.99 10 19 43 56 112
Basic Earnings per Share
($0.52) ($0.30) ($0.17) ($0.93) ($1.22) ($1.50) ($1.21) ($1.49) ($0.65) ($0.47)
Weighted Average Basic Shares Outstanding
110.60M 31.05M 543.19M 55.44M 780.70M 1.09B 1.21B 1.34B 1.36B 1.37B
Diluted Earnings per Share
($0.52) ($0.30) ($0.17) ($0.93) ($1.22) ($1.50) ($1.21) ($1.49) ($0.65) ($0.47)
Weighted Average Diluted Shares Outstanding
110.60M 31.05M 543.19M 55.44M 780.70M 1.09B 1.21B 1.34B 1.36B 1.37B
Weighted Average Basic & Diluted Shares Outstanding
110.60M 434.67M 543.19M 776.20M 120.11M 166.94M 185.57M 206.27M 208.77M 210.58M

Quarterly Income Statements for Beigene

This table shows Beigene's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
-558 -445 -348 -381 215 -368 -251 -120 -121 -152
Consolidated Net Income / (Loss)
-558 -445 -348 -381 215 -368 -251 -120 -121 -152
Net Income / (Loss) Continuing Operations
-558 -445 -348 -381 215 -368 -251 -120 -121 -152
Total Pre-Tax Income
-551 -431 -337 -367 229 -351 -243 -106 -98 -85
Total Operating Income
-438 -469 -371 -319 -134 -384 -261 -107 -120 -79
Total Gross Profit
311 307 366 499 685 529 627 791 831 967
Total Revenue
388 380 448 595 781 634 752 929 1,002 1,128
Operating Revenue
388 380 448 595 781 634 752 929 1,002 1,128
Total Cost of Revenue
77 74 82 96 96 106 125 138 170 161
Operating Cost of Revenue
77 74 82 96 96 106 125 138 170 161
Total Operating Expenses
749 775 737 818 819 912 888 898 951 1,047
Selling, General & Admin Expense
323 330 328 395 366 419 427 444 455 505
Research & Development Expense
426 446 409 423 453 494 461 454 496 542
Total Other Income / (Expense), net
-113 38 34 -49 363 33 18 1.24 22 -5.93
Other Income / (Expense), net
-126 19 18 -64 337 17 1.76 -12 11 -14
Income Tax Expense
6.32 14 11 14 14 17 7.72 14 23 67
Basic Earnings per Share
($0.41) ($0.33) ($0.26) ($0.28) $0.16 ($0.27) ($0.19) ($0.09) ($0.09) ($0.10)
Weighted Average Basic Shares Outstanding
1.35B 1.34B 1.35B 1.36B 1.36B 1.36B 1.36B 1.36B 1.38B 1.37B
Diluted Earnings per Share
($0.41) ($0.33) ($0.26) ($0.28) $0.15 ($0.26) ($0.19) ($0.09) ($0.09) ($0.10)
Weighted Average Diluted Shares Outstanding
1.35B 1.34B 1.35B 1.36B 1.39B 1.36B 1.36B 1.36B 1.38B 1.37B
Weighted Average Basic & Diluted Shares Outstanding
206.97M 206.27M 208.33M 209.27M 211.62M 208.77M 208.55M 209.40M 211.81M 210.58M

Annual Cash Flow Statements for Beigene

This table details how cash moves in and out of Beigene's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
3.97 70 152 505 -120 769 2,993 -508 -689 -547
Net Cash From Operating Activities
-40 -90 13 -548 -750 -1,283 -1,299 -1,497 -1,157 -141
Net Cash From Continuing Operating Activities
-40 -90 13 -548 -750 -1,283 -1,299 -1,497 -1,157 -141
Net Income / (Loss) Continuing Operations
-57 -119 -93 -674 -951 -1,629 -1,458 -2,004 -882 -645
Consolidated Net Income / (Loss)
-57 -119 -93 -674 -951 -1,629 -1,458 -2,004 -882 -645
Depreciation Expense
1.55 1.91 4.76 10 19 32 46 66 88 172
Amortization Expense
- 0.00 - 0.00 0.00 -114 -112 -96 -55 -73
Non-Cash Adjustments To Reconcile Net Income
13 14 50 157 203 281 317 394 68 526
Changes in Operating Assets and Liabilities, net
2.26 14 51 -41 -21 146 -91 143 -376 -120
Net Cash From Investing Activities
-59 -222 -356 -638 554 -3,168 641 1,077 60 -548
Net Cash From Continuing Investing Activities
-59 -222 -356 -638 554 -3,168 641 1,077 60 -548
Purchase of Property, Plant & Equipment
-5.31 -24 -46 -70 -90 -118 -263 -325 -562 -493
Acquisitions
- 0.00 0.00 -109 -69 -110 -52 -144 -34 -36
Purchase of Investments
-119 -382 -741 -2,636 -1,169 -5,690 -2,191 -16 -15 -19
Sale and/or Maturity of Investments
66 184 424 2,177 1,882 2,751 3,147 1,564 673 2.66
Other Investing Activities, net
0.00 0.00 -12 - 0.00 -2.03 - -1.49 -2.08 -2.86
Net Cash From Financing Activities
103 381 490 1,691 86 5,203 3,637 -19 416 193
Net Cash From Continuing Financing Activities
103 381 490 1,691 86 5,203 3,637 -19 416 193
Repayment of Debt
-0.32 0.00 -2.47 -8.74 -33 -144 -322 -417 -323 -729
Issuance of Debt
6.18 381 135 912 67 434 423 351 684 877
Issuance of Common Equity
0.00 0.00 354 787 51 4,325 3,535 47 56 45
Effect of Exchange Rate Changes
-0.49 0.10 5.30 - - - 14 -69 -8.08 -52
Cash Interest Paid
0.13 0.83 1.26 2.21 4.32 44 30 25 20 51
Cash Income Taxes Paid
0.00 0.03 29 12 8.98 11 16 30 56 69

Quarterly Cash Flow Statements for Beigene

This table details how cash moves in and out of Beigene's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
-335 -325 -331 -122 -341 105 -379 -190 95 -75
Net Cash From Operating Activities
-562 -318 -564 -294 -78 -222 -309 -96 188 75
Net Cash From Continuing Operating Activities
-562 -318 -564 -294 -78 -222 -309 -96 188 75
Net Income / (Loss) Continuing Operations
-558 -445 -348 -381 215 -368 -251 -120 -121 -152
Consolidated Net Income / (Loss)
-558 -445 -348 -381 215 -368 -251 -120 -121 -152
Depreciation Expense
16 18 20 22 22 24 25 25 71 50
Amortization Expense
-25 -26 -17 -5.27 -16 -17 -13 -22 -17 -22
Non-Cash Adjustments To Reconcile Net Income
91 132 76 103 -252 141 85 131 118 192
Changes in Operating Assets and Liabilities, net
-87 2.77 -294 -32 -47 -2.12 -155 -109 137 6.77
Net Cash From Investing Activities
169 39 241 68 -186 -63 -210 -111 -134 -94
Net Cash From Continuing Investing Activities
169 39 241 68 -186 -63 -210 -111 -134 -94
Purchase of Property, Plant & Equipment
-109 -121 -126 -121 -158 -157 -157 -110 -134 -92
Other Investing Activities, net
- - -10 -1.27 -4.00 14 -19 -1.08 -0.23 18
Net Cash From Financing Activities
120 -110 -20 166 -77 347 162 23 13 -4.52
Net Cash From Continuing Financing Activities
120 -110 -20 166 -77 347 162 23 13 -4.52
Repayment of Debt
-30 -272 -51 -15 -101 -155 -3.58 -165 -3.56 -557
Issuance of Debt
134 150 0.00 178 7.50 499 151 182 - 544
Issuance of Common Equity
17 11 32 3.58 17 3.36 15 5.56 16 8.80
Effect of Exchange Rate Changes
-63 65 - - - 42 -22 -5.90 28 -52
Cash Interest Paid
6.97 5.30 5.02 5.00 5.88 3.86 11 13 14 13
Cash Income Taxes Paid
0.57 4.49 7.62 25 9.99 13 2.49 43 9.14 15

Annual Balance Sheets for Beigene

This table presents Beigene's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
117 406 1,046 2,250 1,612 5,601 8,536 6,379 5,805 5,921
Total Current Assets
106 374 913 1,944 1,173 4,961 7,614 5,207 4,203 3,992
Cash & Equivalents
18 88 240 713 618 1,382 4,376 3,870 3,172 2,627
Accounts Receivable
- 0.00 29 41 71 60 483 173 358 676
Inventories, net
- 0.00 11 16 29 89 243 282 416 495
Prepaid Expenses
5.78 6.23 36 91 90 160 270 217 257 193
Plant, Property, & Equipment, net
6.61 26 63 157 242 358 588 846 1,324 1,578
Total Noncurrent Assets
3.88 5.44 70 149 197 282 334 326 278 351
Intangible Assets
- 0.00 7.25 7.17 5.85 5.00 47 41 57 51
Other Noncurrent Operating Assets
3.88 4.67 55 99 151 204 280 286 221 300
Total Liabilities & Shareholders' Equity
117 406 1,046 2,250 1,612 5,601 8,536 6,379 5,805 5,921
Total Liabilities
42 53 362 496 634 1,732 2,403 1,996 2,268 2,589
Total Current Liabilities
35 35 150 246 310 1,075 1,600 1,469 1,810 2,215
Short-Term Debt
15 0.00 9.22 8.73 0.00 335 428 329 688 852
Accounts Payable
8.98 12 119 113 122 232 262 295 315 405
Accrued Expenses
8.35 22 - 100 164 346 558 467 694 804
Current Deferred & Payable Income Tax Liabilities
0.00 0.80 9.16 5.89 13 20 21 25 23 26
Other Current Liabilities
2.17 - - - 11 142 143 138 90 129
Total Noncurrent Liabilities
7.27 18 212 250 324 656 803 527 458 374
Long-Term Debt
6.19 17 9.22 41 83 184 202 209 198 166
Noncurrent Deferred & Payable Income Tax Liabilities
- - 0.00 11 11 11 14 16 16 42
Other Noncurrent Operating Liabilities
0.11 0.56 32 49 72 462 367 260 244 165
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-102 353 684 1,754 978 3,869 6,133 4,383 3,537 3,332
Total Preferred & Common Equity
-102 353 670 1,739 962 3,869 6,133 4,383 3,537 3,332
Total Common Equity
-102 353 670 1,739 962 3,869 6,133 4,383 3,537 3,332
Common Stock
18 591 1,001 2,745 2,926 7,415 11,191 11,541 11,599 12,088
Retained Earnings
-118 -237 -331 -1,007 -1,956 -3,553 -5,077 -7,080 -7,962 -8,607
Accumulated Other Comprehensive Income / (Loss)
-1.81 -0.95 -0.48 1.53 -8.00 6.94 18 -77 -99 -149

Quarterly Balance Sheets for Beigene

This table presents Beigene's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
6,726 5,957 5,729 5,525 5,668 5,712 5,831
Total Current Assets
5,749 4,704 4,401 4,054 3,908 3,839 3,912
Cash & Equivalents
4,197 3,539 3,410 3,067 2,793 2,593 2,702
Accounts Receivable
189 310 299 309 435 529 569
Inventories, net
291 297 321 317 447 443 432
Prepaid Expenses
200 265 255 242 232 274 209
Plant, Property, & Equipment, net
682 925 1,032 1,178 1,418 1,516 1,563
Total Noncurrent Assets
295 327 295 293 342 357 356
Intangible Assets
41 40 47 54 55 54 54
Other Noncurrent Operating Assets
251 282 247 240 287 303 302
Total Liabilities & Shareholders' Equity
6,726 5,957 5,729 5,525 5,668 5,712 5,831
Total Liabilities
2,071 1,799 1,930 1,762 2,307 2,346 2,395
Total Current Liabilities
1,411 1,255 1,405 1,283 1,882 1,939 2,025
Short-Term Debt
441 282 421 329 827 852 864
Accounts Payable
252 241 267 342 357 333 308
Accrued Expenses
410 418 455 506 569 647 717
Current Deferred & Payable Income Tax Liabilities
23 34 17 20 27 5.28 15
Other Current Liabilities
140 94 86 87 101 102 122
Total Noncurrent Liabilities
660 545 525 478 426 407 369
Long-Term Debt
208 206 207 202 199 185 188
Noncurrent Deferred & Payable Income Tax Liabilities
15 16 16 16 16 16 16
Other Noncurrent Operating Liabilities
286 285 278 259 210 206 166
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
4,655 4,157 3,799 3,763 3,360 3,366 3,436
Total Preferred & Common Equity
4,655 4,157 3,799 3,763 3,360 3,366 3,436
Total Common Equity
4,655 4,157 3,799 3,763 3,360 3,366 3,436
Common Stock
11,452 11,645 11,752 11,503 11,705 11,840 11,975
Retained Earnings
-6,635 -7,429 -7,810 -7,594 -8,213 -8,334 -8,455
Accumulated Other Comprehensive Income / (Loss)
-162 -59 -144 -145 -132 -140 -84

Annual Metrics and Ratios for Beigene

This table displays calculated financial ratios and metrics derived from Beigene's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
-32.37% -87.86% 22,179.16% -16.85% 116.03% -27.87% 280.83% 20.37% 73.65% 54.96%
EBITDA Growth
-243.01% -109.63% 30.13% -743.56% -34.72% -82.25% 12.54% -37.26% 57.55% 44.40%
EBIT Growth
-221.82% -107.33% 27.26% -709.35% -35.37% -70.06% 12.18% -41.51% 55.31% 35.45%
NOPAT Growth
-260.13% -106.29% 15.89% -616.83% -36.01% -72.69% 13.21% -24.39% 32.52% 52.95%
Net Income Growth
-207.89% -108.78% 21.74% -622.44% -41.03% -71.33% 10.49% -37.45% 56.00% 26.87%
EPS Growth
-188.89% 42.31% 43.33% -447.06% -31.18% -22.95% 19.33% -23.14% 56.38% 27.69%
Operating Cash Flow Growth
-358.28% -124.66% 114.25% -4,395.15% -36.98% -71.07% -1.19% -15.24% 22.66% 87.85%
Free Cash Flow Firm Growth
0.00% -160.16% 12.32% -698.43% -21.94% 13.98% -115.75% -6.11% -13.89% 49.19%
Invested Capital Growth
0.00% 137.48% 466.68% 1,149.56% 63.52% -215.97% 150.73% 181.28% 223.84% 37.66%
Revenue Q/Q Growth
0.00% -81.38% 8.25% 25.68% -0.41% 16.26% 10.72% 13.29% 11.54% 14.88%
EBITDA Q/Q Growth
0.00% -9.78% -195.27% -36.67% -11.86% -7.94% -7.29% 6.48% 10.08% 37.99%
EBIT Q/Q Growth
0.00% -9.66% -180.37% -36.28% -11.56% -6.36% -8.01% 6.20% 8.36% 32.04%
NOPAT Q/Q Growth
0.00% -10.26% -208.36% -33.48% -12.58% -6.21% -6.42% 5.45% 6.56% 34.88%
Net Income Q/Q Growth
0.00% -9.51% -195.09% -33.05% -14.61% -7.44% -7.77% 7.42% 8.11% 25.06%
EPS Q/Q Growth
0.00% 34.78% -54.55% -29.17% -12.96% 0.00% 0.00% 10.24% 9.72% 25.40%
Operating Cash Flow Q/Q Growth
0.00% -11.70% 111.90% -110.60% -10.83% -5.35% -15.63% 11.25% 7.70% 67.85%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 57.77% -120.96% 3.69% -10.53% -13.31% -1.48% 3.97% 32.52%
Invested Capital Q/Q Growth
0.00% -10.12% -93.09% 82.34% -14.56% -19.98% 78.34% 66.58% 12.91% -3.51%
Profitability Metrics
- - - - - - - - - -
Gross Margin
100.00% 100.00% 97.91% 85.52% 83.38% 77.12% 85.98% 79.77% 84.55% 84.41%
EBITDA Margin
-636.52% -10,994.11% -34.48% -349.81% -218.14% -551.16% -126.57% -144.33% -35.28% -12.66%
Operating Margin
-643.66% -10,940.19% -41.30% -356.05% -224.16% -536.69% -122.31% -126.40% -49.12% -14.91%
EBIT Margin
-654.05% -11,172.52% -36.48% -355.05% -222.49% -524.55% -120.96% -142.21% -36.60% -15.24%
Profit (Net Income) Margin
-647.71% -11,141.78% -39.14% -340.04% -221.99% -527.27% -123.93% -141.52% -35.86% -16.92%
Tax Burden Percent
100.00% 100.05% 102.45% 97.71% 100.74% 100.64% 101.34% 102.18% 106.77% 120.97%
Interest Burden Percent
99.03% 99.68% 104.72% 98.02% 99.04% 99.88% 101.11% 97.39% 91.78% 91.76%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% -1,025.06% -640.55% -357.05% 0.00% 0.00% -478.29% -103.23% -26.74%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% -1,020.30% -624.78% -333.39% 0.00% 0.00% -463.26% -102.07% -14.06%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 1,007.07% 585.25% 287.46% 0.00% 0.00% 440.18% 80.96% 7.97%
Return on Equity (ROE)
-76.83% -55.81% -17.99% -55.30% -69.59% -67.19% -29.15% -38.11% -22.26% -18.77%
Cash Return on Invested Capital (CROIC)
0.00% -4,429.35% -1,165.06% -810.91% -405.26% 0.00% -1,030.15% -573.38% -208.85% -58.44%
Operating Return on Assets (OROA)
-49.38% -45.75% -11.98% -42.70% -49.34% -44.92% -20.13% -27.00% -14.77% -9.91%
Return on Assets (ROA)
-48.90% -45.63% -12.85% -40.90% -49.23% -45.16% -20.63% -26.87% -14.47% -11.00%
Return on Common Equity (ROCE)
105.21% -32.81% -17.74% -54.64% -68.81% -66.97% -29.15% -38.11% -22.26% -18.77%
Return on Equity Simple (ROE_SIMPLE)
56.11% -33.78% -13.93% -38.76% -98.79% -42.09% -23.77% -45.71% -24.93% -19.35%
Net Operating Profit after Tax (NOPAT)
-40 -82 -69 -494 -672 -1,160 -1,007 -1,253 -845 -398
NOPAT Margin
-450.56% -7,658.13% -28.91% -249.24% -156.91% -375.68% -85.62% -88.48% -34.38% -10.44%
Net Nonoperating Expense Percent (NNEP)
-43.61% -17.31% -4.76% -15.76% -23.66% -19.17% -8.89% -15.03% -1.16% -12.68%
Return On Investment Capital (ROIC_SIMPLE)
49.05% -22.14% -9.81% -27.40% -63.29% -26.45% -14.89% -25.46% -19.11% -9.14%
Cost of Revenue to Revenue
0.00% 0.00% 2.09% 14.48% 16.62% 22.88% 14.02% 20.23% 15.45% 15.59%
SG&A Expenses to Revenue
82.93% 1,878.22% 26.26% 98.57% 90.67% 194.31% 84.17% 90.30% 61.33% 48.06%
R&D to Revenue
660.73% 9,161.96% 112.85% 342.55% 216.56% 419.23% 124.06% 115.86% 72.34% 51.26%
Operating Expenses to Revenue
743.66% 11,040.19% 139.21% 441.57% 307.54% 613.81% 208.29% 206.16% 133.67% 99.32%
Earnings before Interest and Taxes (EBIT)
-58 -120 -87 -704 -953 -1,620 -1,423 -2,014 -900 -581
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-56 -118 -82 -693 -934 -1,702 -1,489 -2,044 -867 -482
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.00 2.84 6.63 4.79 10.45 6.08 4.15 5.21 5.33 5.91
Price to Tangible Book Value (P/TBV)
0.00 2.84 6.71 4.81 10.51 6.08 4.18 5.26 5.42 6.00
Price to Revenue (P/Rev)
0.00 937.41 18.64 42.04 23.47 76.12 21.61 16.13 7.67 5.17
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 323.32 318.32 46.22 39.26 0.00 141.43 48.74 13.24 10.50
Enterprise Value to Revenue (EV/Rev)
0.00 609.48 15.26 33.30 21.41 62.74 16.52 13.30 6.74 4.75
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 285.32 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.28 0.05 0.03 0.03 0.09 0.13 0.10 0.12 0.25 0.31
Long-Term Debt to Equity
0.08 0.05 0.01 0.02 0.09 0.05 0.03 0.05 0.06 0.05
Financial Leverage
-1.07 -1.01 -0.99 -0.94 -0.86 -1.01 -1.01 -0.95 -0.79 -0.57
Leverage Ratio
1.57 1.22 1.40 1.35 1.41 1.49 1.41 1.42 1.54 1.71
Compound Leverage Factor
1.56 1.22 1.47 1.33 1.40 1.49 1.43 1.38 1.41 1.57
Debt to Total Capital
21.86% 4.67% 2.62% 2.75% 7.85% 11.82% 9.31% 10.93% 20.03% 23.40%
Short-Term Debt to Total Capital
15.35% 0.00% 1.31% 0.48% 0.00% 7.64% 6.32% 6.68% 15.56% 19.57%
Long-Term Debt to Total Capital
6.51% 4.67% 1.31% 2.26% 7.85% 4.19% 2.99% 4.25% 4.47% 3.83%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
185.15% 0.00% 2.05% 0.80% 1.52% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
-107.00% 95.33% 95.32% 96.45% 90.63% 88.18% 90.69% 89.07% 79.97% 76.60%
Debt to EBITDA
-0.37 -0.15 -0.22 -0.07 -0.09 -0.30 -0.42 -0.26 -1.02 -2.11
Net Debt to EBITDA
1.42 2.98 9.96 2.52 0.96 2.43 4.02 1.96 2.64 3.34
Long-Term Debt to EBITDA
-0.11 -0.15 -0.11 -0.06 -0.09 -0.11 -0.14 -0.10 -0.23 -0.35
Debt to NOPAT
-0.52 -0.21 -0.27 -0.10 -0.12 -0.45 -0.63 -0.43 -1.05 -2.56
Net Debt to NOPAT
2.01 4.28 11.88 3.54 1.34 3.56 5.95 3.19 2.70 4.05
Long-Term Debt to NOPAT
-0.16 -0.21 -0.13 -0.08 -0.12 -0.16 -0.20 -0.17 -0.23 -0.42
Altman Z-Score
0.00 10.59 7.75 9.41 6.77 7.19 5.95 5.19 3.48 3.21
Noncontrolling Interest Sharing Ratio
236.93% 41.22% 1.39% 1.18% 1.12% 0.33% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
3.02 10.68 6.09 7.89 3.78 4.61 4.76 3.55 2.32 1.80
Quick Ratio
2.86 10.50 5.78 7.40 3.40 4.38 4.44 3.21 1.95 1.49
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-34 -89 -78 -625 -763 -656 -1,415 -1,502 -1,710 -869
Operating Cash Flow to CapEx
-749.92% -380.94% 27.50% -779.30% -837.24% -1,092.23% -493.92% -459.88% -205.99% -28.55%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 -19.07 0.00 0.00 0.00 -89.82 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 3.10 0.00 0.00 0.00 -82.42 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 -8.18 0.00 0.00 0.00 -99.11 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.08 0.00 0.33 0.12 0.22 0.09 0.17 0.19 0.40 0.65
Accounts Receivable Turnover
0.00 0.00 0.00 5.62 7.65 4.71 4.33 4.32 9.26 7.37
Inventory Turnover
0.00 0.00 0.00 2.11 3.18 1.20 0.99 1.09 1.09 1.30
Fixed Asset Turnover
1.33 0.07 5.38 1.81 2.14 1.03 2.49 1.98 2.27 2.63
Accounts Payable Turnover
0.00 0.00 0.08 0.25 0.60 0.40 0.67 1.03 1.25 1.65
Days Sales Outstanding (DSO)
0.00 0.00 0.00 64.89 47.71 77.57 84.33 84.59 39.43 49.54
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 172.75 114.83 304.38 367.33 334.44 335.52 279.89
Days Payable Outstanding (DPO)
0.00 0.00 4,818.75 1,479.20 604.41 915.50 547.10 354.95 292.97 221.21
Cash Conversion Cycle (CCC)
0.00 0.00 -4,818.75 -1,241.55 -441.87 -533.54 -95.44 64.07 81.98 108.21
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
-5.38 2.02 11 143 234 -271 137 386 1,252 1,723
Invested Capital Turnover
-3.28 -0.64 35.46 2.57 2.28 -16.57 -17.63 5.41 3.00 2.56
Increase / (Decrease) in Invested Capital
-5.38 7.40 9.41 131 91 -504 408 249 865 471
Enterprise Value (EV)
0.00 652 3,638 6,601 9,168 19,380 19,432 18,837 16,576 18,084
Market Capitalization
0.00 1,003 4,443 8,333 10,052 23,512 25,420 22,834 18,861 19,693
Book Value per Share
($0.92) $0.82 $1.13 $2.25 $1.22 $3.27 $5.03 $3.25 $2.60 $2.40
Tangible Book Value per Share
($0.92) $0.82 $1.12 $2.24 $1.21 $3.27 $4.99 $3.22 $2.56 $2.37
Total Capital
95 370 703 1,803 1,062 4,388 6,762 4,921 4,423 4,350
Total Debt
21 17 18 50 83 519 630 538 886 1,018
Total Long-Term Debt
6.19 17 9.22 41 83 184 202 209 198 166
Net Debt
-80 -351 -819 -1,746 -900 -4,132 -5,988 -3,997 -2,286 -1,609
Capital Expenditures (CapEx)
5.31 23 46 70 90 118 263 325 562 493
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-15 -29 -65 -90 -121 -430 -176 -467 -90 0.81
Debt-free Net Working Capital (DFNWC)
86 339 773 1,706 862 4,221 6,442 4,068 3,082 2,628
Net Working Capital (NWC)
71 339 764 1,697 862 3,885 6,014 3,739 2,393 1,777
Net Nonoperating Expense (NNE)
17 37 24 180 279 468 451 751 36 247
Net Nonoperating Obligations (NNO)
-80 -351 -673 -1,611 -745 -4,140 -5,995 -3,997 -2,286 -1,609
Total Depreciation and Amortization (D&A)
1.55 1.91 4.76 10 19 -82 -66 -30 32 99
Debt-free, Cash-free Net Working Capital to Revenue
-167.77% -2,694.67% -27.18% -45.34% -28.17% -139.37% -14.97% -33.02% -3.67% 0.02%
Debt-free Net Working Capital to Revenue
972.04% 31,714.11% 324.15% 860.72% 201.39% 1,366.42% 547.65% 287.27% 125.33% 68.98%
Net Working Capital to Revenue
806.45% 31,714.11% 320.28% 856.32% 201.39% 1,257.95% 511.30% 264.04% 97.34% 46.63%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($0.52) ($0.30) ($0.17) ($0.93) ($1.22) ($1.47) ($1.17) ($1.49) ($0.65) ($0.47)
Adjusted Weighted Average Basic Shares Outstanding
110.60M 518.60M 696.34M 776.11M 1.01B 1.19B 1.21B 1.34B 1.36B 1.37B
Adjusted Diluted Earnings per Share
($0.52) ($0.30) ($0.17) ($0.93) ($1.22) ($1.47) ($1.17) ($1.49) ($0.65) ($0.47)
Adjusted Weighted Average Diluted Shares Outstanding
110.60M 518.60M 696.34M 776.11M 1.01B 1.19B 1.21B 1.34B 1.36B 1.37B
Adjusted Basic & Diluted Earnings per Share
($0.52) ($0.30) ($0.17) ($0.93) ($1.22) ($1.47) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
110.60M 403.62M 543.19M 776.20M 780.70M 1.17B 185.57M 206.27M 208.77M 210.58M
Normalized Net Operating Profit after Tax (NOPAT)
-40 -82 -69 -494 -672 -1,160 -1,007 -1,253 -845 -398
Normalized NOPAT Margin
-450.56% -7,658.13% -28.91% -249.24% -156.91% -375.68% -85.62% -88.48% -34.38% -10.44%
Pre Tax Income Margin
-647.71% -11,136.73% -38.20% -348.01% -220.35% -523.90% -122.30% -138.50% -33.59% -13.99%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 -21.17 0.00 0.00 0.00 -90.30 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 -16.78 0.00 0.00 0.00 -63.92 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 -32.46 0.00 0.00 0.00 -106.99 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 -28.07 0.00 0.00 0.00 -80.60 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% -1.86% -0.72% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for Beigene

This table displays calculated financial ratios and metrics derived from Beigene's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
87.77% 77.63% 46.04% 74.27% 101.56% 66.91% 67.85% 56.09% 28.20% 77.78%
EBITDA Growth
-27.92% 23.66% 19.75% 36.70% 136.38% 21.27% 29.38% 68.23% -126.03% 82.07%
EBIT Growth
-30.90% 22.86% 18.17% 32.77% 135.94% 18.29% 26.45% 68.85% -153.75% 74.62%
NOPAT Growth
5.18% 18.04% 16.25% 27.47% 58.99% 18.10% 29.60% 66.38% 33.10% 79.31%
Net Income Growth
-27.26% 26.49% 19.94% 32.63% 138.64% 17.47% 27.92% 68.41% -156.33% 58.68%
EPS Growth
-13.89% 34.00% 21.21% 33.33% 136.59% 21.21% 26.92% 67.86% -160.00% 61.54%
Operating Cash Flow Growth
-13.35% 37.34% -138.32% 22.65% 86.09% 30.34% 45.27% 67.47% 341.04% 133.91%
Free Cash Flow Firm Growth
26.28% 28.62% -6.92% -54.27% -117.03% -96.45% -17.34% -2.43% 24.05% 53.52%
Invested Capital Growth
201.14% 181.28% 233.36% 460.55% 377.78% 223.84% 97.25% 101.22% 61.08% 37.66%
Revenue Q/Q Growth
13.48% -1.94% 17.81% 32.93% 31.25% -18.80% 18.48% 23.62% 7.80% 12.60%
EBITDA Q/Q Growth
0.82% 20.16% 23.37% -4.32% 157.00% -272.81% 31.26% 53.07% 53.30% -18.98%
EBIT Q/Q Growth
0.88% 20.36% 21.42% -8.38% 152.99% -281.09% 29.28% 54.10% 8.56% 14.49%
NOPAT Q/Q Growth
0.24% -6.90% 20.78% 14.15% 43.60% -113.50% 31.90% 59.00% -12.23% 33.96%
Net Income Q/Q Growth
1.44% 20.13% 21.76% -9.39% 156.52% -270.63% 31.67% 52.06% -0.78% -25.16%
EPS Q/Q Growth
2.38% 19.51% 21.21% -7.69% 153.57% -273.33% 26.92% 52.63% 0.00% -11.11%
Operating Cash Flow Q/Q Growth
-47.89% 43.37% -77.18% 47.87% 73.41% -183.61% -39.22% 69.02% 297.06% -60.10%
Free Cash Flow Firm Q/Q Growth
25.97% -24.97% -42.99% -16.62% -4.15% -13.12% 14.59% -1.80% 22.78% 30.78%
Invested Capital Q/Q Growth
44.53% 66.58% 108.97% 11.41% 23.19% 12.91% 27.28% 13.66% -1.38% -3.51%
Profitability Metrics
- - - - - - - - - -
Gross Margin
80.25% 80.66% 81.74% 83.87% 87.67% 83.32% 83.38% 85.13% 82.98% 85.76%
EBITDA Margin
-147.72% -120.28% -78.24% -61.40% 26.66% -56.74% -32.92% -12.50% -5.41% -5.72%
Operating Margin
-113.09% -123.29% -82.91% -53.54% -17.15% -60.50% -34.77% -11.53% -12.01% -7.04%
EBIT Margin
-145.50% -118.18% -78.82% -64.26% 25.94% -57.86% -34.54% -12.82% -10.88% -8.26%
Profit (Net Income) Margin
-143.84% -117.16% -77.81% -64.03% 27.57% -57.94% -33.41% -12.96% -12.12% -13.47%
Tax Burden Percent
101.15% 103.33% 103.41% 103.72% 93.93% 104.78% 103.17% 113.68% 123.44% 177.95%
Interest Burden Percent
97.74% 95.94% 95.46% 96.06% 113.15% 95.57% 93.77% 88.90% 90.23% 91.62%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 6.07% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-640.29% -466.54% -172.15% -128.02% -52.98% -127.14% -56.02% -18.45% -19.27% -12.63%
ROIC Less NNEP Spread (ROIC-NNEP)
-633.79% -464.19% -170.18% -124.09% -62.62% -123.99% -53.35% -16.41% -17.54% -7.69%
Return on Net Nonoperating Assets (RNNOA)
609.34% 441.07% 152.39% 109.63% 52.65% 98.35% 36.32% 10.20% 10.49% 4.36%
Return on Equity (ROE)
-30.95% -25.47% -19.76% -18.39% -0.33% -28.79% -19.70% -8.25% -8.78% -8.27%
Cash Return on Invested Capital (CROIC)
-957.77% -573.38% -336.75% -350.31% -265.77% -208.85% -129.46% -112.99% -89.00% -58.44%
Operating Return on Assets (OROA)
-30.28% -22.44% -17.56% -17.76% 9.34% -23.35% -16.42% -6.94% -6.35% -5.37%
Return on Assets (ROA)
-29.93% -22.25% -17.34% -17.69% 9.92% -23.38% -15.88% -7.01% -7.08% -8.75%
Return on Common Equity (ROCE)
-30.95% -25.47% -19.76% -18.39% -0.33% -28.79% -19.70% -8.25% -8.78% -8.27%
Return on Equity Simple (ROE_SIMPLE)
-46.49% 0.00% -46.11% -45.61% -25.50% 0.00% -23.34% -15.56% -25.04% 0.00%
Net Operating Profit after Tax (NOPAT)
-307 -328 -260 -223 -126 -269 -183 -75 -84 -56
NOPAT Margin
-79.16% -86.30% -58.03% -37.48% -16.11% -42.35% -24.34% -8.07% -8.41% -4.93%
Net Nonoperating Expense Percent (NNEP)
-6.51% -2.35% -1.97% -3.93% 9.64% -3.15% -2.67% -2.04% -1.73% -4.94%
Return On Investment Capital (ROIC_SIMPLE)
-5.78% -6.67% -5.59% -5.04% -2.93% -6.07% -4.17% -1.70% -1.88% -1.28%
Cost of Revenue to Revenue
19.75% 19.34% 18.26% 16.13% 12.33% 16.68% 16.62% 14.87% 17.02% 14.24%
SG&A Expenses to Revenue
83.30% 86.75% 73.36% 66.36% 46.81% 66.01% 56.87% 47.76% 45.45% 44.75%
R&D to Revenue
109.99% 117.35% 91.24% 71.02% 58.01% 77.87% 61.28% 48.91% 49.54% 48.06%
Operating Expenses to Revenue
193.34% 203.95% 164.64% 137.42% 104.82% 143.81% 118.15% 96.67% 94.99% 92.81%
Earnings before Interest and Taxes (EBIT)
-564 -449 -353 -383 203 -367 -260 -119 -109 -93
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-573 -457 -350 -365 208 -360 -247 -116 -54 -65
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
3.01 5.21 5.41 4.92 5.06 5.33 4.87 4.43 6.93 5.91
Price to Tangible Book Value (P/TBV)
3.03 5.26 5.46 4.98 5.13 5.42 4.95 4.50 7.04 6.00
Price to Revenue (P/Rev)
11.20 16.13 14.44 10.32 8.64 7.67 5.92 4.82 7.18 5.17
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
41.28 48.74 23.70 17.55 14.78 13.24 9.16 7.38 12.42 10.50
Enterprise Value to Revenue (EV/Rev)
7.66 13.30 12.29 8.72 7.43 6.74 5.28 4.32 6.69 4.75
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.14 0.12 0.12 0.17 0.14 0.25 0.31 0.31 0.31 0.31
Long-Term Debt to Equity
0.04 0.05 0.05 0.05 0.05 0.06 0.06 0.06 0.05 0.05
Financial Leverage
-0.96 -0.95 -0.90 -0.88 -0.84 -0.79 -0.68 -0.62 -0.60 -0.57
Leverage Ratio
1.50 1.42 1.39 1.44 1.46 1.54 1.55 1.60 1.58 1.71
Compound Leverage Factor
1.47 1.36 1.33 1.38 1.65 1.47 1.45 1.42 1.42 1.56
Debt to Total Capital
12.24% 10.93% 10.51% 14.20% 12.37% 20.03% 23.39% 23.55% 23.43% 23.40%
Short-Term Debt to Total Capital
8.32% 6.68% 6.07% 9.51% 7.65% 15.56% 18.85% 19.34% 19.25% 19.57%
Long-Term Debt to Total Capital
3.92% 4.25% 4.44% 4.69% 4.72% 4.47% 4.54% 4.21% 4.18% 3.83%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
87.76% 89.07% 89.49% 85.80% 87.63% 79.97% 76.61% 76.45% 76.57% 76.60%
Debt to EBITDA
-0.30 -0.26 -0.25 -0.36 -0.55 -1.02 -1.34 -2.01 -1.35 -2.11
Net Debt to EBITDA
2.02 1.96 1.71 1.66 2.75 2.64 2.31 3.02 2.12 3.34
Long-Term Debt to EBITDA
-0.10 -0.10 -0.11 -0.12 -0.21 -0.23 -0.26 -0.36 -0.24 -0.35
Debt to NOPAT
-0.49 -0.43 -0.41 -0.56 -0.59 -1.05 -1.34 -1.67 -1.72 -2.56
Net Debt to NOPAT
3.34 3.19 2.78 2.59 2.93 2.70 2.30 2.51 2.70 4.05
Long-Term Debt to NOPAT
-0.16 -0.17 -0.17 -0.19 -0.22 -0.23 -0.26 -0.30 -0.31 -0.42
Altman Z-Score
3.36 6.00 6.51 4.62 5.68 3.78 2.99 2.65 4.83 3.48
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
4.07 3.55 3.75 3.13 3.16 2.32 2.08 1.98 1.93 1.80
Quick Ratio
3.73 3.21 3.30 2.72 2.71 1.95 1.72 1.61 1.62 1.49
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-462 -577 -825 -962 -1,002 -1,134 -968 -986 -761 -527
Operating Cash Flow to CapEx
-517.15% -262.19% -448.92% -241.94% -49.50% -141.21% -197.07% -86.94% 140.94% 81.27%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.21 0.19 0.22 0.28 0.36 0.40 0.48 0.54 0.58 0.65
Accounts Receivable Turnover
7.84 4.32 6.22 7.68 8.85 9.26 7.42 7.47 7.55 7.37
Inventory Turnover
1.18 1.09 1.12 1.12 1.14 1.09 1.14 1.22 1.44 1.30
Fixed Asset Turnover
2.21 1.98 2.01 2.18 2.37 2.27 2.36 2.43 2.42 2.63
Accounts Payable Turnover
1.14 1.03 1.27 1.31 1.17 1.25 1.42 1.55 1.66 1.65
Days Sales Outstanding (DSO)
46.55 84.59 58.65 47.52 41.25 39.43 49.21 48.84 48.32 49.54
Days Inventory Outstanding (DIO)
308.40 334.44 326.80 324.84 319.12 335.52 321.09 299.95 253.30 279.89
Days Payable Outstanding (DPO)
319.83 354.95 288.04 279.07 311.82 292.97 257.93 235.38 219.73 221.21
Cash Conversion Cycle (CCC)
35.11 64.07 97.41 93.29 48.55 81.98 112.37 113.41 81.89 108.21
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
232 386 808 900 1,108 1,252 1,593 1,811 1,785 1,723
Invested Capital Turnover
8.09 5.41 2.97 3.42 3.29 3.00 2.30 2.29 2.29 2.56
Increase / (Decrease) in Invested Capital
155 249 565 739 876 865 785 911 677 471
Enterprise Value (EV)
9,577 18,837 19,139 15,792 16,387 16,576 14,587 13,365 22,174 18,084
Market Capitalization
13,997 22,834 22,484 18,689 19,042 18,861 16,355 14,920 23,824 19,693
Book Value per Share
$3.45 $3.25 $3.07 $2.79 $2.73 $2.60 $2.48 $2.48 $2.49 $2.40
Tangible Book Value per Share
$3.42 $3.22 $3.04 $2.75 $2.70 $2.56 $2.44 $2.44 $2.45 $2.37
Total Capital
5,305 4,921 4,645 4,427 4,294 4,423 4,386 4,403 4,487 4,350
Total Debt
649 538 488 628 531 886 1,026 1,037 1,051 1,018
Total Long-Term Debt
208 209 206 207 202 198 199 185 188 166
Net Debt
-4,420 -3,997 -3,345 -2,897 -2,655 -2,286 -1,767 -1,556 -1,651 -1,609
Capital Expenditures (CapEx)
109 121 126 121 158 157 157 110 134 92
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-290 -467 -101 -108 -87 -90 60 159 48 0.81
Debt-free Net Working Capital (DFNWC)
4,779 4,068 3,732 3,417 3,099 3,082 2,853 2,752 2,750 2,628
Net Working Capital (NWC)
4,338 3,739 3,450 2,996 2,770 2,393 2,026 1,900 1,886 1,777
Net Nonoperating Expense (NNE)
251 117 89 158 -341 99 68 45 37 96
Net Nonoperating Obligations (NNO)
-4,423 -3,997 -3,350 -2,899 -2,655 -2,286 -1,767 -1,556 -1,651 -1,609
Total Depreciation and Amortization (D&A)
-8.61 -8.00 2.61 17 5.61 7.09 12 3.03 55 29
Debt-free, Cash-free Net Working Capital to Revenue
-23.22% -33.02% -6.50% -5.99% -3.95% -3.67% 2.16% 5.14% 1.46% 0.02%
Debt-free Net Working Capital to Revenue
382.39% 287.27% 239.65% 188.72% 140.57% 125.33% 103.27% 88.87% 82.92% 68.98%
Net Working Capital to Revenue
347.08% 264.04% 221.55% 165.47% 125.67% 97.34% 73.34% 61.37% 56.87% 46.63%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($0.41) ($0.33) ($0.26) ($0.28) $0.16 ($0.27) ($0.19) ($0.09) ($0.09) ($0.10)
Adjusted Weighted Average Basic Shares Outstanding
1.35B 1.34B 1.35B 1.36B 1.36B 1.36B 1.36B 1.36B 1.38B 1.37B
Adjusted Diluted Earnings per Share
($0.41) ($0.33) ($0.26) ($0.28) $0.15 ($0.26) ($0.19) ($0.09) ($0.09) ($0.10)
Adjusted Weighted Average Diluted Shares Outstanding
1.35B 1.34B 1.35B 1.36B 1.39B 1.36B 1.36B 1.36B 1.38B 1.37B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
206.97M 206.27M 208.33M 209.27M 211.62M 208.77M 208.55M 209.40M 211.81M 210.58M
Normalized Net Operating Profit after Tax (NOPAT)
-307 -328 -260 -223 -126 -269 -183 -75 -84 -56
Normalized NOPAT Margin
-79.16% -86.30% -58.03% -37.48% -16.11% -42.35% -24.34% -8.07% -8.41% -4.93%
Pre Tax Income Margin
-142.21% -113.38% -75.24% -61.73% 29.35% -55.29% -32.39% -11.40% -9.81% -7.57%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Beigene's Financials

When does Beigene's fiscal year end?

According to the most recent income statement we have on file, Beigene's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Beigene's net income changed over the last 9 years?

Beigene's net income appears to be on an upward trend, with a most recent value of -$644.79 million in 2024, rising from -$57.10 million in 2015. The previous period was -$881.71 million in 2023.

What is Beigene's operating income?
Beigene's total operating income in 2024 was -$568.20 million, based on the following breakdown:
  • Total Gross Profit: $3.22 billion
  • Total Operating Expenses: $3.78 billion
How has Beigene revenue changed over the last 9 years?

Over the last 9 years, Beigene's total revenue changed from $8.82 million in 2015 to $3.81 billion in 2024, a change of 43,119.6%.

How much debt does Beigene have?

Beigene's total liabilities were at $2.59 billion at the end of 2024, a 14.1% increase from 2023, and a 5,998.9% increase since 2015.

How much cash does Beigene have?

In the past 9 years, Beigene's cash and equivalents has ranged from $17.87 million in 2015 to $4.38 billion in 2021, and is currently $2.63 billion as of their latest financial filing in 2024.

How has Beigene's book value per share changed over the last 9 years?

Over the last 9 years, Beigene's book value per share changed from -0.92 in 2015 to 2.40 in 2024, a change of -361.3%.

Remove Ads


This page (NASDAQ:ONC) was last updated on 4/13/2025 by MarketBeat.com Staff
From Our Partners